Chargement en cours...
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA)
Chemotherapy remains the mainstay of treatment for advanced pancreatic ductal adenocarcinoma (pda). Two randomized trials have demonstrated superiority of the combination regimens folfirinox (5-fluorouracil, leucovorin, oxaliplatin, and irinotecan) and gemcitabine plus nab-paclitaxel over gemcitabin...
Enregistré dans:
| Publié dans: | Curr Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832297/ https://ncbi.nlm.nih.gov/pubmed/29507500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3708 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|